Literature DB >> 25657445

Pyoderma gangrenosum in a patient with pemphigus vulgaris: an unusual association.

Vinay Keshavamurthy1, Amrinder J Kanwar1, Uma N Saikia2.   

Abstract

Entities:  

Year:  2015        PMID： 25657445      PMCID： PMC4318051          DOI： 10.4103/0019-5154.147892

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN： 0019-5154            Impact factor:   1.494


× No keyword cloud information.
  5 in total

1.  The influence of systemic therapy on the serum levels of IL-6 and IL-8 in pemphigus vulgaris.

Authors:  H Mortazavi; F Babaeijandaghi; M Akbarzadeh; N Rezaei; A A Amirzargar; M Daneshpazhooh; A Jalali; Z Hallaji
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-11-02       Impact factor: 6.166

2.  Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts.

Authors:  M Oka; C Berking; M Nesbit; K Satyamoorthy; H Schaider; G Murphy; M Ichihashi; E Sauter; M Herlyn
Journal:  Lab Invest       Date:  2000-04       Impact factor: 5.662

Review 3.  Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria.

Authors:  W P Daniel Su; Mark D P Davis; Roger H Weenig; Frank C Powell; Harold O Perry
Journal:  Int J Dermatol       Date:  2004-11       Impact factor: 2.736

4.  Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy.

Authors:  Derin B Keskin; Joel N H Stern; Masha Fridkis-Hareli; A Razzaque Ahmed
Journal:  Cytokine       Date:  2008-03       Impact factor: 3.861

5.  Pyostomatitis vegetans and its relation to inflammatory bowel disease, pyoderma gangrenosum, pyodermatitis vegetans, and pemphigus.

Authors:  Marcello M S Nico; Thais P Hussein; Valeria Aoki; Silvia V Lourenço
Journal:  J Oral Pathol Med       Date:  2012-05-05       Impact factor: 4.253
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.